Literature DB >> 9505896

Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats.

I Shimizu1, M Yasuda, Y Mizobuchi, Y R Ma, F Liu, M Shiba, T Horie, S Ito.   

Abstract

AIMS: To examine the effects of oestradiol and testosterone on the early carcinogenic changes expressed in rat liver from the diethylnitrosamine (DEN), 2-acetylaminofluorene (AAF), partial hepatectomy (PH) model of hepatocarcinogenesis.
METHODS: Preneoplastic liver lesions were evaluated using immunohistochemical analysis of glutathione-S-transferase placental form (GST-P) expression; oestrogen and androgen receptor levels were measured by radioimmunoassay.
RESULTS: Oestradiol administration to non-castrated DEN-AAF-PH treated males resulted in a decrease in the area of GST-P positive foci, while testosterone increased the serum oestradiol level and reduced the area. In males, castration alone and castration with oestradiol replacement significantly reduced the GST-P positive area, and increased the hepatic oestrogen receptor level. In DEN-AAF-PH treated females, castration with testosterone replacement was associated with a significant increase in the GST-P positive area and the hepatic androgen receptor level.
CONCLUSION: These findings suggest that exogenous and endogenous oestradiol can suppress chemical hepatocarcinogenesis. It appears that oestrogen receptors may be involved in the inhibition of malignant transformation of preneoplastic liver cells, while androgens and androgen receptors are involved in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505896      PMCID: PMC1726966          DOI: 10.1136/gut.42.1.112

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

Review 1.  Hepatoma associated with androgen therapy for aplastic anemia.

Authors:  A T Meadows; J L Naiman; M Valdes-Dapena
Journal:  J Pediatr       Date:  1974-01       Impact factor: 4.406

2.  Hepatic adenoma in Fanconi anemia treated with oxymetholone.

Authors:  J J Mulvihill; R L Ridolfi; F R Schultz; M S Borzy; P B Haughton
Journal:  J Pediatr       Date:  1975-07       Impact factor: 4.406

3.  Scatchard plots: common errors in correction and interpretation.

Authors:  G C Chamness; W L McGuire
Journal:  Steroids       Date:  1975-10       Impact factor: 2.668

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats.

Authors:  H S Taper
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

6.  Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.

Authors:  P J Johnson; N Krasner; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

7.  Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.

Authors:  J D Yager; R Yager
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

8.  Estrogen-binding proteins of male rat liver: influences of hormonal changes.

Authors:  P K Eagon; S E Fisher; A F Imhoff; L E Porter; R R Stewart; D H Van Thiel; R Lester
Journal:  Arch Biochem Biophys       Date:  1980-05       Impact factor: 4.013

9.  Hepatomas: hormone receptors and therapy.

Authors:  M A Friedman; D J Demanes; P G Hoffman
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

10.  Stimulation of DNA synthesis and cell proliferation in the liver of rats fed a choline-devoid diet and their suppression by phenobarbital.

Authors:  S E Abanobi; B Lombardi; H Shinozuka
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

View more
  23 in total

1.  Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.

Authors:  Zhaoyu Li; Geetu Tuteja; Jonathan Schug; Klaus H Kaestner
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

Review 2.  Interplay of estrogen receptors and FOXA factors in the liver cancer.

Authors:  Yongbing Zhao; Zhaoyu Li
Journal:  Mol Cell Endocrinol       Date:  2015-02-04       Impact factor: 4.102

3.  Age-dependent sensitivity of Big Blue transgenic mice to the mutagenicity of N-ethyl-N-nitrosourea (ENU) in liver.

Authors:  Nan Mei; Robert H Heflich; Martha M Moore; Tao Chen
Journal:  Mutat Res       Date:  2005-05-02       Impact factor: 2.433

4.  Apoptotic and anti-proliferative effects of 17beta-estradiol and 17beta-estradiol-like compounds in the Hep3B cell line.

Authors:  Erh-Jung Huang; Cheng-Chung Wu; Hsien-Ping Huang; Jer-Yuh Liu; Chung-Sheng Lin; Yan-Zin Chang; James A Lin; Jaung-Geng Lin; Li-Mien Chen; Shin-Da Lee; Wei-Wen Kuo; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2006-08-19       Impact factor: 3.396

5.  Protective effect of estradiol on hepatocytic oxidative damage.

Authors:  Yan Liu; Ichiro Shimizu; Toshihiro Omoya; Susumu Ito; Xiao-Song Gu; Ji Zuo
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression.

Authors:  Yong-Cang Wang; Ge-Liang Xu; Wei-Dong Jia; Sheng-Jin Han; Wei-Hua Ren; Wei Wang; Wen-Bin Liu; Chuan-Hai Zhang; Hao Chen
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

7.  Clinicopathological and Prognostic Significance of Klotho and Estrogen Receptors Expression in Human Hepatocellular Carcinoma.

Authors:  Shu Huang; Wei Wang; Yajun Cheng; Jie Lin; Min Wang
Journal:  Turk J Gastroenterol       Date:  2021-10       Impact factor: 1.852

Review 8.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

Review 9.  Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.

Authors:  Ichiro Shimizu; Nao Kohno; Katsuyoshi Tamaki; Masayuki Shono; Hui-Wei Huang; Jiang-Hong He; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

Review 10.  Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Authors:  Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li
Journal:  Cancer Lett       Date:  2018-09-14       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.